182 related articles for article (PubMed ID: 23845467)
1. Epithelial-to-mesenchymal transition and stem cells in endometrial cancer.
Mirantes C; Espinosa I; Ferrer I; Dolcet X; Prat J; Matias-Guiu X
Hum Pathol; 2013 Oct; 44(10):1973-81. PubMed ID: 23845467
[TBL] [Abstract][Full Text] [Related]
2. Epithelial to mesenchymal transition in early stage endometrioid endometrial carcinoma.
Montserrat N; Mozos A; Llobet D; Dolcet X; Pons C; de Herreros AG; Matias-Guiu X; Prat J
Hum Pathol; 2012 May; 43(5):632-43. PubMed ID: 21940036
[TBL] [Abstract][Full Text] [Related]
3. Epithelial-mesenchymal transition and cancer stem cells in endometrial cancer.
Supernat A; Lapinska-Szumczyk S; Majewska H; Gulczynski J; Biernat W; Wydra D; Zaczek AJ
Anticancer Res; 2013 Dec; 33(12):5461-9. PubMed ID: 24324082
[TBL] [Abstract][Full Text] [Related]
4. Stromal Clues in Endometrial Carcinoma: Loss of Expression of β-Catenin, Epithelial-Mesenchymal Transition Regulators, and Estrogen-Progesterone Receptor.
Senol S; Sayar I; Ceyran AB; Ibiloglu I; Akalin I; Firat U; Kosemetin D; Engin Zerk P; Aydin A
Int J Gynecol Pathol; 2016 May; 35(3):238-48. PubMed ID: 26367784
[TBL] [Abstract][Full Text] [Related]
5. The comparison of clinicopathological characteristics in primary malignant mixed műllerian tumour with epithelial endometrial carcinoma.
Tong SY; Lee JM; Choi YJ; Lee JK; Kim JW; Cho CH; Kim SM; Park SY; Park CY; Kim KT
Aust N Z J Obstet Gynaecol; 2012 Feb; 52(1):44-8. PubMed ID: 22188343
[TBL] [Abstract][Full Text] [Related]
6. Role of epithelial-mesenchymal transition factors in the histogenesis of uterine carcinomas.
Franceschi T; Durieux E; Morel AP; de Saint Hilaire P; Ray-Coquard I; Puisieux A; Devouassoux-Shisheboran M
Virchows Arch; 2019 Jul; 475(1):85-94. PubMed ID: 30739164
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of microRNA-194 suppresses the epithelial-mesenchymal transition in targeting stem cell transcription factor Sox3 in endometrial carcinoma stem cells.
Gong B; Yue Y; Wang R; Zhang Y; Jin Q; Zhou X
Tumour Biol; 2017 Jun; 39(6):1010428317706217. PubMed ID: 28618953
[TBL] [Abstract][Full Text] [Related]
8. HOTAIR in relation to epithelial-mesenchymal transition and cancer stem cells in molecular subtypes of endometrial cancer.
Łuczak A; Supernat A; Łapińska-Szumczyk S; Jachimowicz D; Majewska H; Gulczyński J; Żaczek AJ
Int J Biol Markers; 2016 Jul; 31(3):e245-51. PubMed ID: 26868332
[TBL] [Abstract][Full Text] [Related]
9. Evidence for cancer stem cells in human endometrial carcinoma.
Hubbard SA; Friel AM; Kumar B; Zhang L; Rueda BR; Gargett CE
Cancer Res; 2009 Nov; 69(21):8241-8. PubMed ID: 19843861
[TBL] [Abstract][Full Text] [Related]
10. The inhibitory effect of salinomycin on the proliferation, migration and invasion of human endometrial cancer stem-like cells.
Kusunoki S; Kato K; Tabu K; Inagaki T; Okabe H; Kaneda H; Suga S; Terao Y; Taga T; Takeda S
Gynecol Oncol; 2013 Jun; 129(3):598-605. PubMed ID: 23500085
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinases 2 and 9, E-cadherin, and beta-catenin expression in endometriosis, low-grade endometrial carcinoma and non-neoplastic eutopic endometrium.
Shaco-Levy R; Sharabi S; Benharroch D; Piura B; Sion-Vardy N
Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):226-32. PubMed ID: 18295959
[TBL] [Abstract][Full Text] [Related]
12. Epithelial-to-mesenchymal transition: what is the impact on breast cancer stem cells and drug resistance.
Mallini P; Lennard T; Kirby J; Meeson A
Cancer Treat Rev; 2014 Apr; 40(3):341-8. PubMed ID: 24090504
[TBL] [Abstract][Full Text] [Related]
13. Clinical translation for endometrial cancer stem cells hypothesis.
Carvalho MJ; Laranjo M; Abrantes AM; Torgal I; Botelho MF; Oliveira CF
Cancer Metastasis Rev; 2015 Sep; 34(3):401-16. PubMed ID: 26224131
[TBL] [Abstract][Full Text] [Related]
14. Correspondence re: Mikami Y, Hata S, Kiyokawa T, Manabe T. Expression of CD10 in malignant mullerian mixed tumors and adenosarcomas: an immunohistochemical study. Mod pathol 2002;15:923-30.
Zamecnik M
Mod Pathol; 2003 Jun; 16(6):618-9; author reply 619. PubMed ID: 12808069
[No Abstract] [Full Text] [Related]
15. The impact of microRNA-mediated PI3K/AKT signaling on epithelial-mesenchymal transition and cancer stemness in endometrial cancer.
Dong P; Konno Y; Watari H; Hosaka M; Noguchi M; Sakuragi N
J Transl Med; 2014 Aug; 12():231. PubMed ID: 25141911
[TBL] [Abstract][Full Text] [Related]
16. Association between Morphological Patterns of Myometrial Invasion and Cancer Stem Cell Markers in Endometrial Endometrioid Carcinoma.
Park JY; Hong D; Park JY
Pathol Oncol Res; 2019 Jan; 25(1):123-130. PubMed ID: 28990139
[TBL] [Abstract][Full Text] [Related]
17. Molecular events in endometrial carcinosarcomas and the role of high mobility group AT-hook 2 in endometrial carcinogenesis.
Romero-Pérez L; Castilla MÁ; López-García MÁ; Díaz-Martín J; Biscuola M; Ramiro-Fuentes S; Oliva E; Matias-Guiu X; Prat J; Cano A; Moreno-Bueno G; Palacios J
Hum Pathol; 2013 Feb; 44(2):244-54. PubMed ID: 22974476
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of EMT (epithelial-mesenchymal-transition)-related protein expression in endometrial cancer.
Tanaka Y; Terai Y; Kawaguchi H; Fujiwara S; Yoo S; Tsunetoh S; Takai M; Kanemura M; Tanabe A; Ohmichi M
Cancer Biol Ther; 2013 Jan; 14(1):13-9. PubMed ID: 23114646
[TBL] [Abstract][Full Text] [Related]
19. Tumor budding and E-Cadherin expression in endometrial carcinoma: are they prognostic factors in endometrial cancer?
Koyuncuoglu M; Okyay E; Saatli B; Olgan S; Akin M; Saygili U
Gynecol Oncol; 2012 Apr; 125(1):208-13. PubMed ID: 22198340
[TBL] [Abstract][Full Text] [Related]
20. Uterine malignant mixed mullerian tumors should not be included in studies of endometrial carcinoma.
Vaidya AP; Horowitz NS; Oliva E; Halpern EF; Duska LR
Gynecol Oncol; 2006 Nov; 103(2):684-7. PubMed ID: 16797683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
